Endometriosis drug shows early promise for 190 million patients

· Science

An experimental drug for endometriosis, a condition affecting roughly 190 million people worldwide, has shown early signs of efficacy, according to a Nature News report. Endometriosis is often called a 'missed disease' because it is frequently underdiagnosed and lacks targeted treatments.

Why it matters：A disease with a vast patient population and few effective options represents a major commercial and public-health opportunity; positive early data could draw more investment into women's health research.

Key points

  • Endometriosis affects an estimated 190 million people, making it one of the most common gynecological conditions.
  • The condition is often called a 'missed disease' due to diagnostic delays and limited treatment options.

Sources (original reporting)

More stories from this day